About The Course:
Most organizations have programs and procedures but they contain holes or fall short in the implementation of the tools and techniques used to apply proper statistical reasoning and analysis to ICH guidelines. Statistics can help you to better understand, implement, and track processes covered by the ICH guidelines?
This 2-day seminar explores the unique challenges facing quality functions of pharmaceutical and biotechnology companies. Attendees will learn practical implementation solutions as well as best practice descriptions that will allow management to effectively assess, manage and mitigate risk of poorly designed studies. Participants will learn statistical methods related to ICH guidelines and will discover how regulatory agencies, such as the FDA expect organizations to meet these guidelines.
This seminar will provide attendees with an understanding of the fourteen ICH Quality guidelines as relates to statistical guidance and analysis. The course will provide tools, techniques and insight that will allow participants to immediately begin implementation of the information learned within their organization/firm.
|WHO SHOULD ATTEND
- Quality Assurance Departments
- Quality Control Departments
- Analytical Validation scientists and personnel
- Assay Development Scientists
- Quality Analysts
- Research Scientists
- Risk Managers
- Upon completion of the course, you will be able to:
- Compare FDA requirements to ICH guidelines.
- Perform comparative analyses and regression analysis.
- Know the difference between confidence and tolerance intervals.
- Calculate the appropriate sample size.
- Calculate the probability of risk.
- Design and perform statistical tests for comparisons, stability, validation, impurities
ICH review and Statistics Fundamentals
- Review ICH Quality Guidelines (Q Series)
- Q1 Stability Testing
- Q2 Analytical Validation
- Q3A-3E Impurities
- Q4 Pharmacopoeias
- Q5A-5E Quality of Biotechnological Products
- Q6A-6B Specifications
- Q7 Good Manufacturing Practice
- Q8 Pharmaceutical Development
- Q9 Quality Risk Management
- Q10 Pharmaceutical Quality System
- Q11 Development and Manufacture of Drug Substances
- Q12 Lifecycle Management
- Q13 Continuous Manufacturing of Drug Substances and Drub Products
- Q14 Analytical Procedure Development
- Developing a Quality Risk Management Plan
- Fundamentals of Statistics
- Normal Distribution
- Descriptive and Summary Statistics
- Graphical Techniques
- Null Hypothesis Statistical Testing
- Confidence and Tolerance Intervals
- Statistical vs. Meaningful Significance
Statistical Tests and Applications to Industry Behaviors
- Statistical Analyses
- Comparative Statistics
- Regression Analysis
- Sample Size (Power Analysis)
- Application to Industry
- Design of Experiments (DOE)
- Setting Specifications/Thresholds/Acceptance Criteria
- Stability/Shelf-Life Testing
- Assay Validation
COURSE DIRECTOR: ELAINE EISENBEISZ
Elaine Eisenbeisz is a private practice statistician and owner of Omega Statistics, a statistical consulting firm based in Southern California. Elaine has over 30 years of experience in creating data and information solutions for industries ranging from governmental agencies and corporations, to start-up companies and individual researchers.
Elaine’s love of numbers began in elementary school where she placed in regional and statewide mathematics competitions. She attended University of California, Riverside, as a National Science Foundation scholar, where she earned a B.S. in Statistics with a minor in Quantitative Management, Accounting. Elaine received her Master’s Certification in Applied Statistics from Texas A&M, and is currently finishing her graduate studies at Rochester Institute of Technology. Elaine is a member in good standing with the American Statistical Association as well as many other professional organizations. She is also a member of the Mensa High IQ Society. Omega Statistics holds an A+ rating with the Better Business Bureau.
Elaine has designed the methodology for numerous studies in the clinical, biotech, and health care fields. She currently is an investigator on approximately 10 proton therapy clinical trials for Proton Collaborative Group, based in Illinois. She also designs and analyzes studies as a contract statistician for nutriceutical and fitness studies with QPS, a CRO based in Delaware. Elaine has also worked as a contract statistician with numerous private researchers and biotech start-ups as well as with larger companies such as Allergan and Rio Tinto Minerals. Not only is Elaine well versed in statistical methodology and analysis, she works well with project teams. Throughout her tenure as a private practice statistician, she has published work with researchers and colleagues in peer-reviewed journals. Please visit the Omega Statistics website at www.OmegaStatistics.com to learn more about Elaine and Omega Statistics.